Concepedia

Heike Helmbach

HH

Statistics

Publications

6

Citations

412

H-Index

6

Active since

1998

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

Charité - Universitätsmedizin Berlin

University Medical Centre Mannheim

DKFZ-ZMBH Alliance

Heike Helmbach is an author at Heidelberg University specializing in oncology, molecular drug resistance, and chemotherapy.

Publications per year

1998–2003

6

Publications

6

DFNA5 (ICERE‐1) contributes to acquired etoposide resistance in melanoma cells

Hermann Lage, Heike Helmbach, Claudia Grottke et al. · FEBS Letters · 2001 · 115 citations

, , +13

Candidate genes for cross-resistance against DNA-damaging drugs.

Rainer Wittig, Rainer Will, Jan Mollenhauer et al. · PubMed · 2002 · 68 citations

, , +17

Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

Hermann Lage, Heike Helmbach, Manfred Dietel et al. · British Journal of Cancer · 2000 · 63 citations · Full text

, , +14

Drug Resistance Towards Etoposide and Cisplatin in Human Melanoma Cells is Associated with Drug-Dependent Apoptosis Deficiency

Heike Helmbach, Monika Kern, Evelyn Rossmann et al. · Journal of Investigative Dermatology · 2002 · 61 citations · Full text

, , +16

Study of the development of chemoresistance in melanoma cell lines using proteome analysis

Pranav Sinha, Julia Poland, Sandro Kohl et al. · Electrophoresis · 2003 · 54 citations

, , +17

1–5 of 6